Violation Tracker Individual Record
Company:TAP Pharmaceutical Products, Inc.
Date:December 19, 2001
Offense Group:government-contracting-related offenses
Primary Offense:False Claims Act and related
TAP Pharmaceutical Products, Inc. agreed to pay $525,780 to settle charges of illegal marketing practices for the drug Lupron.
Level of Government:state
Action Type:agency action
Agency:Arkansas Attorney General
Civil or Criminal Case:civil
HQ Country of Parent:Japan
Ownership Structure of Parent:publicly traded
Major Industry of Parent:pharmaceuticals
Specific Industry of Parent:pharmaceuticals
Source Notes:If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.